Medicine and Dentistry
Adjuvant Chemotherapy
27%
Adjuvant Therapy
100%
Breast Cancer
100%
CMF (Chemotherapy)
9%
Cyclophosphamide
9%
Disease Free Survival
45%
Diseases
18%
Estrogen Receptor
81%
Fluorouracil
9%
Lymph Node
100%
Malignant Neoplasm
18%
Methotrexate
9%
Neoplasm
36%
Overall Survival
45%
Tamoxifen
100%
Nursing and Health Professions
Adjuvant Chemotherapy
27%
Adjuvant Therapy
100%
Breast Cancer
100%
Confidence Interval
72%
Cyclophosphamide
9%
Disease Free Survival
45%
Diseases
18%
Estrogen Receptor
81%
Fluorouracil
9%
Malignant Neoplasm
18%
Methotrexate
9%
Neoplasm
36%
Overall Survival
45%
Tamoxifen
100%
Pharmacology, Toxicology and Pharmaceutical Science
Breast Cancer
100%
Chemotherapy
45%
Cyclophosphamide
9%
Disease Free Survival
45%
Diseases
18%
Estrogen Receptor
81%
Fluorouracil
9%
Malignant Neoplasm
18%
Methotrexate
9%
Neoplasm
36%
Overall Survival
45%
Tamoxifen
100%
Agricultural and Biological Sciences
Confidence Interval
72%
Estrogen Receptor
81%
Lymph Node
100%
Tamoxifen
100%
Immunology and Microbiology
Cyclophosphamide
20%
Disease Free Survival
100%
Lymph Node
100%
Methotrexate
20%
Overall Survival
100%